Two Sigma Advisers’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
93,800
-99,500
| -51% | -$1.39M | ﹤0.01% | 1308 |
|
|
2025
Q1 | $2.61M | Sell |
193,300
-142,269
| -42% | -$1.92M | 0.01% | 1051 |
|
|
2024
Q4 | $6.43M | Sell |
335,569
-109,231
| -25% | -$2.09M | 0.01% | 619 |
|
|
2024
Q3 | $10.1M | Sell |
444,800
-81,900
| -16% | -$1.86M | 0.02% | 486 |
|
|
2024
Q2 | $6.85M | Buy |
526,700
+222,300
| +73% | +$2.89M | 0.02% | 655 |
|
|
2024
Q1 | $5.33M | Buy |
304,400
+204,100
| +203% | +$3.57M | 0.01% | 757 |
|
|
2023
Q4 | $2.18M | Buy |
100,300
+80,000
| +394% | +$1.74M | 0.01% | 1240 |
|
|
2023
Q3 | $311K | Buy |
20,300
+10,800
| +114% | +$166K | ﹤0.01% | 1968 |
|
|
2023
Q2 | $226K | Buy |
+9,500
| New | +$226K | ﹤0.01% | 2062 |
|